Cefpodoxime shortage status
1 active shortage notice across 1 country.
Last updated 10 Jul 2026 · sourced from official medicines regulators
- Generic name (INN)
- Cefpodoxime
- Brand names
- Cefpodoxima Mylan, Cefpodoxima Sandoz
- ATC code
- J01DD13
- Class
- Canonical INN head (inn_resolution)
Where Cefpodoxime is in shortage
Why Cefpodoxime is in shortage
- manufacturing problems — e.g. “The sample does not conform to I.P. w.r.to the tests for Identification and Assay Spurious” (India)
Frequently asked questions
Is Cefpodoxime currently in shortage?
Yes. As of the latest regulator updates, Cefpodoxime has 1 active shortage notice across 1 country (India). Status is refreshed daily from official regulatory sources.
Why is Cefpodoxime in shortage?
Regulators attribute the current Cefpodoxime shortages to manufacturing problems. The exact cause varies by country and product — each notice on this page links to the official source.
Where does this Cefpodoxime shortage data come from?
Every shortage notice on this page is scraped daily from an official national medicines regulator (such as the FDA, TGA, MHRA or EMA) and linked back to its source. Mederti aggregates 40+ regulators across 50+ countries and never publishes unsourced shortage claims.
Related medicines
Cefalexin · Cefalexin-Monohydrate · Cephalexin · Cephalexin(250 Mg (Potency)) · Cefazolin · Cefadroxil
Get alerted when Cefpodoxime status changes
Free for individual pharmacists and clinicians — watchlists, email alerts, alternatives and country-by-country product detail.
Create a free accountData on this page is aggregated from official national medicines regulators and updated daily. It is provided for information only and requires verification before clinical use. Mederti is not affiliated with or endorsed by any regulator.